Investigating the link between false positive newborn hearing screenings and autism spectrum disorder
False positive newborn hearing screening results and autism spectrum disorder
This study is looking into whether false positive results from hearing tests for newborns might be linked to the later development of autism in children, helping us find ways to spot autism earlier and support those who might be at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-10645073 on NIH RePORTER |
What this research studies
This research explores the potential connection between false positive results from newborn hearing screenings and the development of autism spectrum disorder (ASD) in children. By analyzing data from the Michigan Department of Health and Human Services, the study aims to determine if auditory brainstem responses (ABRs), which are assessed during these screenings, can serve as early biomarkers for ASD. The research will focus on understanding whether these false positives are associated with ASD symptoms and how they relate to other risk factors. This could provide valuable insights into early diagnosis and intervention strategies for children at risk of ASD.
Who could benefit from this research
Good fit: Ideal candidates for this research include infants who have received false positive results from newborn hearing screenings.
Not a fit: Patients who have not undergone newborn hearing screenings or those who do not exhibit any risk factors for autism spectrum disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection and intervention for children at risk of autism spectrum disorder.
How similar studies have performed: Previous research has shown promising results in using biomarkers for early diagnosis of autism, suggesting that this approach may yield valuable insights.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Talge, Nicole — Michigan State University
- Study coordinator: Talge, Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.